Who is ppds biotech? PDS Biotech is a clinical stage biopharmaceutical company with a growing pipeline of cancer immunotherapies and infectious disease vaccines. Our team is committed to developing first-in-class T-cell activating immunotherapies and preventive vaccines based on the Versamune platform to fight against cancer and infectious diseases.Will pds biotechnology corporation report pds0101 clinical data? PDS Biotechnology Corporation (NASDAQ: PDSB) will be reporting preliminary Phase 2 clinical data of its lead compound PDS0101 for the treatment of advanced HPV-associated cancers in patients whose cance...Why is pds biotechnology pdsb shares trading higher tuesday morning? PDS Biotechnology Corp (NASDAQ:PDSB) shares are trading higher by 13.3% at $10.65 Tuesday morning after the company highlighted the release of interim data for PDS0101 in an NCI-led Phase 2 clinical stu... CORRECTING AND REPLACING -- PDS Biotech Announces Release of Interim Data for PDS0101 in NCI-Led Phase 2 Clinical Stu...
About Us. PDS Biotech is a clinical stage biopharmaceutical company with a growing pipeline of cancer immunotherapies and infectious disease vaccines. Our team is committed to developing first-in-class T-cell activating immunotherapies and preventive vaccines based on the Versamune platform to fight against cancer and infectious diseases.